Conversion to AbobotulinumtoxinA Increases Waning Time and Efficacy for Cervical Dystonia

BACKGROUND: Symptom re‐emergence before re‐injection negatively impacts cervical dystonia (CD) patients receiving botulinum toxin type A (BoNT‐A) therapy. Longer waning time is associated with abobotulinumtoxinA (abo‐BoNT‐A) as compared to onabotulinumtoxinA (ona‐BoNT‐A)/incobotulinumtoxinA (inco‐Bo...

Descripción completa

Detalles Bibliográficos
Autores principales: Samotus, Olivia, Jog, Mandar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2023
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186996/
https://www.ncbi.nlm.nih.gov/pubmed/37205243
http://dx.doi.org/10.1002/mdc3.13696

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186996/
https://www.ncbi.nlm.nih.gov/pubmed/37205243
http://dx.doi.org/10.1002/mdc3.13696

Ejemplares similares